IMR Press / CEOG / Volume 44 / Issue 2 / DOI: 10.12891/ceog3316.2017

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 47 Issue 1 (2020). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with S.O.G.

Case Report
Dextroamphetamine sulfate provided quick relief of severe post-partum depression that was recalcitrant to standard antidepressants and psychotherapy
Show Less
1 Cooper Medical School of Rowan University, Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology & Infertility, Camden, NJ, USA
2 Franklin and Marshall College, Lancaster, PA, USA
Clin. Exp. Obstet. Gynecol. 2017, 44(2), 272–274;
Published: 10 April 2017

Purpose: To determine if dextroamphetamine sulfate could improve symptoms of post-partum depression. Materials and Methods: A woman with severe post-partum depression that was resistant to standard antidepressant therapy and psychotherapy was treated with dextroamphetamine sulfate extended release capsules 15 mg/day. Results: A quick and complete abrogation of the depression ensued along with improvement of migraine headaches, insomnia, and chronic fatigue. Conclusions: Dextroamphetamine sulfate should be considered as a treatment modality for post-partum depression.
Dextroamphetamine sulfate
Post-partum depression
Chronic fatigue
Back to top